NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/07/2023
Back to search
Official data from USPTO
PRIME PATH MEDTECH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PRIME PATH MEDTECH
ST13
US500000090818082Class
35, 42
Filing
90818082
Registration
7213921
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
11/07/2023
Trademark type
Word
Nice classes
35, 42
Filing date
07/08/2021
Registration date
11/07/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/07/2023
Last transaction
11/07/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2019-10-00
First use in commerce
2019-10-00
Drawing code
4
Owner type
03
Owner location
Houston, TX
Examiner
SWAIN, MICHELE
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Prime Path Medtech, Inc.
Representatives
Leela Madan MADAN LAW PLLC
Technical classification
Nice Classes
Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Providing business consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval
Class 42
Product development consultation in the field of medical devicesdesign prototyping of medical devices and conducting quality system safety audits in the field of medical device designtesting of medical devicesall for purposes of medical device application approval
Publications
History of USPTO decisions and trademark events.
39 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
11/07/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/04/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/03/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/23/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/23/2023
IUAF
USE AMENDMENT FILED
09/19/2023
EISU
TEAS STATEMENT OF USE RECEIVED
09/19/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/05/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/11/2023
PUBO
PUBLISHED FOR OPPOSITION
07/11/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/27/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/27/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/27/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/21/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/03/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/18/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/18/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/18/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/15/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/15/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/15/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/23/2022
GNRT
NON-FINAL ACTION E-MAILED
11/23/2022
CNRT
NON-FINAL ACTION WRITTEN
11/23/2022
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
11/22/2022
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
11/01/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/17/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/20/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/19/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/19/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/22/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/22/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/22/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/06/2022
GNRT
NON-FINAL ACTION E-MAILED
04/06/2022
CNRT
NON-FINAL ACTION WRITTEN
04/06/2022
DOCK
ASSIGNED TO EXAMINER
03/28/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/15/2021
Continuous trademark protection
Get notified about every new filing that threatens PRIME PATH MEDTECH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.